This course has expired. View available courses.
Musculoskeletal Health, Neurology
Targeting Unmet Needs in the Treatment of Focal Spasticity
The management of spasticity can be complex. The common treatment for focal spasticity is botulinum toxin-A (BoNT-A) therapy. As the effects of BoNT-A wear off, the recurrence of symptoms can be distressing to patients and may have a significant impact on quality of life. This program describes how patients can be affected and outlines multi-modal approaches to the management of disruptive symptoms in order to improve patient outcomes.
This program has received an educational grant or in-kind support from Ipsen Biopharmaceuticals Canada Inc.
DURATION
30 min
PROFESSION
Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-05-03
The management of spasticity can be complex. The common treatment for focal spasticity is botulinum toxin-A (BoNT-A) therapy. As the effects of BoNT-A wear off, the recurrence of symptoms can be distressing to patients and may have a significant impact on quality of life. This program describes how patients can be affected and outlines multi-modal approaches to the management of disruptive symptoms in order to improve patient outcomes.
This program has received an educational grant or in-kind support from Ipsen Biopharmaceuticals Canada Inc.
Faculty
Heather Finlayson, MD, FRCPC, Dip. Sport Med, CSCN (EMG)
Colleen O’Connell, MD, FRCPC
Omar D. Khan, MD, FRCPC
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the frequency and impact of symptom recurrence between botulinum toxin-A (BoNT-A) injections
- Discuss multi-modal treatment considerations in persons experiencing problematic spasticity while treated with BoNT-A
- Select appropriate treatment options for patients who experience disruptive symptoms towards the end of their treatment cycle
#
of credits: 0
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Specialist
Profession
0
# of credits
Learning Objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the frequency and impact of symptom recurrence between botulinum toxin-A (BoNT-A) injections
- Discuss multi-modal treatment considerations in persons experiencing problematic spasticity while treated with BoNT-A
- Select appropriate treatment options for patients who experience disruptive symptoms towards the end of their treatment cycle
Unaccredited
ACCREDITATION
Musculoskeletal Health, Neurology
Learning Category
Medication
Topic
0
Price
2023-05-03
Expiry Date
CAN-eng
Region/Language
Course Description
The management of spasticity can be complex. The common treatment for focal spasticity is botulinum toxin-A (BoNT-A) therapy. As the effects of BoNT-A wear off, the recurrence of symptoms can be distressing to patients and may have a significant impact on quality of life. This program describes how patients can be affected and outlines multi-modal approaches to the management of disruptive symptoms in order to improve patient outcomes.
This program has received an educational grant or in-kind support from Ipsen Biopharmaceuticals Canada Inc.
Faculty
Heather Finlayson, MD, FRCPC, Dip. Sport Med, CSCN (EMG)
Colleen O’Connell, MD, FRCPC
Omar D. Khan, MD, FRCPC
Accreditation
30 min
Duration
0
Price
0
# of credits
